MedTrace Logo

Sideritis Supplementation, Oxidative Stress and Health

NCT05729659 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2023-12-14

No results posted yet for this study

Summary

The aim of the present clinical study is to estimate the efficacy of a Sideritis Scardica extract (SidTea+), derived from the Greek mountain Taygetos, in regulating antioxidant and health biomarkers in healthy adults.

Conditions

  • Oxidative Stress
  • Lipidemia

Interventions

DIETARY_SUPPLEMENT

Sideritis Scardica (SidTea+) extract supplementation

1500 mg of Sideritis Scardica (SidTea+) extract per day, divided into 3 equal doses of 500 mg (every 8 hours) for a total duration of 1 month

DIETARY_SUPPLEMENT

Placebo supplementation

1500 mg of placebo per day, divided into 3 equal doses of 500 mg (every 8 hours) for a total duration of 1 month

Sponsors & Collaborators

  • University of Thessaly

    lead OTHER

Principal Investigators

  • Athanasios Z. Jamurtas, Professor · University of Thessaly

  • Konstantinos Papanikolaou, PhD · University of Thessaly

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-02-15
Primary Completion
2023-05-25
Completion
2023-10-01

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05729659 on ClinicalTrials.gov